Ricoh Announces Sale of Ricoh 3D for Healthcare, LLC

EXTON, PA, July 6, 2026 – Ricoh USA, Inc. (Ricoh) today announced the sale of Ricoh 3D for Healthcare, LLC, its patient‑specific medical device business, to Myrava, Inc., a company focused on providing access to personalized medical devices and healthcare innovations across the United States.

The decision reflects Ricoh’s continued efforts to sharpen its strategic focus on process automation, workplace experience, and business process services—prioritizing investments in scalable businesses that align most closely with its primary mission and strengths.

“While healthcare remains a key growth area for Ricoh, patient‑specific medical devices require specialized capabilities that extend beyond the scope of our broader business priorities,” said Bob Lamendola, Chief Digital Services and Delivery Officer, Ricoh USA, Inc. “This move enables the business to scale under dedicated ownership, while allowing Ricoh to concentrate on the areas where we deliver the greatest value—helping healthcare providers reduce cost and administrative burden, facilitate regulatory compliance, improve operational efficiency, and measurably support better patient and clinician experiences through our scalable, reliable services and technology.”

Ricoh 3D for Healthcare, LLC was established as a separate and wholly-owned subsidiary in June 2025 to serve hospitals and clinical partners with greater agility in the FDA‑regulated patient‑specific medical device market.

“Ricoh took an important step last year by establishing Ricoh 3D for Healthcare, LLC as a standalone entity, creating the focus and structure needed to serve a highly specialized and rapidly growing market,” said Gary Turner, CEO of Myrava, Inc. and formerly Vice President and General Manager of Ricoh 3D for Healthcare, LLC. “This acquisition is a natural next step in that evolution. As an independent company, Myrava, Inc. will benefit from dedicated investment and leadership fully focused on advancing personalized, FDA‑cleared medical devices and point‑of‑care manufacturing for healthcare providers.”